Oruka Therapeutics, Inc. (ORKA)
93.55
+1.35
(+1.46%)
USD |
NASDAQ |
Sep 16, 16:00
94.44
+0.89
(+0.95%)
After-Hours: 07:57
Oruka Therapeutics Total Liabilities (Quarterly) : 24.84M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.84M |
| March 31, 2026 | 17.76M |
| December 31, 2025 | 16.69M |
| September 30, 2025 | 22.46M |
| June 30, 2025 | 13.78M |
| March 31, 2025 | 12.39M |
| December 31, 2024 | 13.80M |
| September 30, 2024 | 18.88M |
| June 30, 2024 | 1.271M |
| March 31, 2024 | 1.581M |
| December 31, 2023 | 0.841M |
| September 30, 2023 | 1.216M |
| June 30, 2023 | 1.845M |
| March 31, 2023 | 1.528M |
| December 31, 2022 | 1.412M |
| September 30, 2022 | 2.238M |
| June 30, 2022 | 3.138M |
| March 31, 2022 | 3.076M |
| December 31, 2021 | 3.881M |
| September 30, 2021 | 3.592M |
| June 30, 2021 | 4.13M |
| March 31, 2021 | 3.274M |
| December 31, 2020 | 3.908M |
| September 30, 2020 | 1.527M |
| June 30, 2020 | 1.328M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.155M |
| December 31, 2019 | 0.926M |
| September 30, 2019 | 1.15M |
| June 30, 2019 | 1.199M |
| March 31, 2019 | 1.288M |
| December 31, 2018 | 0.793M |
| September 30, 2018 | 0.982M |
| June 30, 2018 | 1.069M |
| March 31, 2018 | 1.734M |
| December 31, 2017 | 2.09M |
| September 30, 2017 | 2.569M |
| June 30, 2017 | 2.549M |
| March 31, 2017 | 2.553M |
| December 31, 2016 | 2.435M |
| September 30, 2016 | 2.199M |
| June 30, 2016 | 1.744M |
| March 31, 2016 | 2.344M |
| December 31, 2015 | 1.504M |
| September 30, 2015 | 1.304M |
| June 30, 2015 | 1.357M |
| March 31, 2015 | 1.134M |
| December 31, 2014 | 1.391M |
| September 30, 2014 | 0.841M |
| June 30, 2014 | 1.219M |
| March 31, 2014 | 1.121M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 8.073M |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 10.42M |
| Century Therapeutics, Inc. | 54.66M |
| Absci Corp. | 22.79M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.139B |
| Shareholders Equity (Quarterly) | 1.115B |
| Debt to Equity Ratio | 0.0023 |
| Current Ratio | 38.51 |
| Net Debt Paydown Yield | -0.01% |